Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Deferred Taxes (2020 - 2022)

Historic Deferred Taxes for BioCorRx (BICX) over the last 3 years, with Q1 2022 value amounting to -$28829.0.

  • BioCorRx's Deferred Taxes fell 1277.63% to -$28829.0 in Q1 2022 from the same period last year, while for Mar 2022 it was -$109556.0, marking a year-over-year decrease of 2063.11%. This contributed to the annual value of -$106290.0 for FY2021, which is 2685.28% down from last year.
  • Per BioCorRx's latest filing, its Deferred Taxes stood at -$28829.0 for Q1 2022, which was down 1277.63% from -$27969.0 recorded in Q4 2021.
  • In the past 5 years, BioCorRx's Deferred Taxes registered a high of -$18534.0 during Q1 2020, and its lowest value of -$28829.0 during Q1 2022.
  • In the last 3 years, BioCorRx's Deferred Taxes had a median value of -$25563.0 in 2021 and averaged -$24323.2.
  • Per our database at Business Quant, BioCorRx's Deferred Taxes crashed by 3792.78% in 2021 and then crashed by 1277.63% in 2022.
  • BioCorRx's Deferred Taxes (Quarter) stood at -$24775.0 in 2020, then dropped by 12.89% to -$27969.0 in 2021, then dropped by 3.07% to -$28829.0 in 2022.
  • Its last three reported values are -$28829.0 in Q1 2022, -$27969.0 for Q4 2021, and -$26680.0 during Q3 2021.